Lean Toward Tocilizumab as an Add-On to Steroids for COVID-19
August 2021
You’ll need to apply the latest evidence for IL-6 inhibitors and Janus kinase (JAK) inhibitors to treat hospitalized COVID-19 patients.
Continue to use a steroid for COVID-19 patients on supplemental oxygen. But compare add-on options...and know when to use them.
A large meta-analysis suggests IL-6 inhibitors, mainly tocilizumab (Actemra), decrease mortality in COVID-19 patients receiving supplemental oxygen...and also taking a steroid.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote